Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To make a preliminary assessment of the efficacy of neoadjuvant treatment of trastuzumab and docetaxel as compared to trastuzumab, pertuzumab and docetaxel as compared to trastuzumab and pertuzumab and pertuzumab and docetaxel compared to trastuzumab, pertuzumab and docetaxel, in patients with T2-4d HER2 positive breast cancer, based on complete pathological response rate.
Inclusion criteria
- Locally advanced, inflammatory or early stage HER2 positive breast cancer